Minghui Pharmaceutical is based in Shanghai, China. It has raised $131M in total funding. Backed by OrbiMed, Qiming Venture Partners, TF Capital.
Minghui Pharmaceutical funding overview
Minghui Pharmaceutical is based in Shanghai, China. Minghui Pharmaceutical has raised $131M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Minghui Pharmaceutical runs through 2025; nothing later has been disclosed. Investors on record include OrbiMed, Qiming Venture Partners, TF Capital, BioTrack Capital, 5Y Capital, New Day Fund and 1 others. 7 distinct backers are named across the disclosed rounds.
Minghui Pharmaceutical at a glance
Total raised
$131M
Latest round date
August 2025
Headquarters
Shanghai, China
Notable investors
OrbiMed, Qiming Venture Partners, TF Capital, BioTrack Capital, 5Y Capital, New Day Fund, Wider Link Enterprise Investment
Frequently asked about Minghui Pharmaceutical funding
How much has Minghui Pharmaceutical raised?
Minghui Pharmaceutical has raised $131M in total disclosed funding across the rounds on record.
Who has invested in Minghui Pharmaceutical?
OrbiMed, Qiming Venture Partners, TF Capital, BioTrack Capital, 5Y Capital, New Day Fund are named among the investors backing Minghui Pharmaceutical.
What was the latest Minghui Pharmaceutical funding round?
No round stage has been disclosed for Minghui Pharmaceutical.
Where is Minghui Pharmaceutical based?
Minghui Pharmaceutical is based in Shanghai, China.
When did Minghui Pharmaceutical last raise?
The last disclosed Minghui Pharmaceutical round closed in August 2025.
Round data for Minghui Pharmaceutical is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
